Extract notice to the Minister

NAT-Bosentan

Common name / Subject : bosentan
Name of the manufacturer : Natco
Form : Co.
Dosage : 62,5 mg, 125 mg

Indication :

INESSS' Recommendation
Inscription - Avec conditions

Minister's decisions
Inscrire aux listes des médicaments - Médicament d'exception

Evaluation published on April 11, 2019

Subscribe to our newsletter now

Subscription